SUROLAN- miconazole nitrate, polymyxin b sulfate, and prednisolone acetate suspension/ drops

País: Estados Unidos

Idioma: inglés

Fuente: NLM (National Library of Medicine)

Ingredientes activos:

miconazole nitrate (UNII: VW4H1CYW1K) (miconazole - UNII:7NNO0D7S5M), polymyxin B sulfate (UNII: 19371312D4) (polymyxin B - UNII:J2VZ07J96K), prednisolone acetate (UNII: 8B2807733D) (prednisolone - UNII:9PHQ9Y1OLM)

Disponible desde:

Vetoquinol USA Inc

Designación común internacional (DCI):

miconazole nitrate

Composición:

miconazole nitrate 23 mg in 1 mL

Vía de administración:

AURICULAR (OTIC)

tipo de receta:

PRESCRIPTION

indicaciones terapéuticas:

SUROLAN is indicated for the treatment of canine otitis externa associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius ). SUROLAN is contraindicated in dogs with suspected or known hypersensitivity to miconazole nitrate, polymyxin B sulfate, or prednisolone acetate. Do not use in dogs with known perforated tympanum. Do not use with drugs known to induce ototoxicity.

Resumen del producto:

SUROLAN is available in 15 mL and 30 mL plastic dispensing bottles with applicator tip for otic use. Store at or below 25 °C (77 °F).

Estado de Autorización:

New Animal Drug Application

Ficha técnica

SUROLAN- MICONAZOLE NITRATE, POLYMYXIN B SULFATE, AND PREDNISOLONE
ACETATE SUSPENSION/
DROPS
VETOQUINOL USA INC
----------
SUROLAN
otic suspension
(miconazole nitrate, polymyxin B sulfate, prednisolone acetate)
RX
Antifungal, antibacterial and anti-inflammatory
_For otic use in dogs only_
CAUTION
Federal (USA) law restricts this drug to use by or on the order of a
licensed veterinarian.
DESCRIPTION
SUROLAN contains 23 mg/mL miconazole nitrate, 0.5293 mg/mL polymyxin B
sulfate and 5 mg/mL
prednisolone acetate. Inactive ingredients are colloidal silicon
dioxide and liquid paraffin.
INDICATIONS
SUROLAN is indicated for the treatment of canine otitis externa
associated with susceptible strains of
yeast (_Malassezia pachydermatis)_ and bacteria (_Staphylococcus
pseudintermedius_).
DOSAGE AND ADMINISTRATION
Shake well before use.
The external ear should be thoroughly cleaned and dried before the
initiation of treatment. Verify that
the eardrum is intact. Instill 5 drops of SUROLAN in the ear canal
twice daily and massage the ear.
Therapy should continue for 7 consecutive days.
CONTRAINDICATIONS
SUROLAN is contraindicated in dogs with suspected or known
hypersensitivity to miconazole nitrate,
polymyxin B sulfate, or prednisolone acetate.
Do not use in dogs with known perforated tympanum. Do not use with
drugs known to induce
ototoxicity.
WARNINGS
Not for use in humans. Keep this and all drugs out of reach of
children.
ANIMAL WARNINGS
Do not administer orally.
For otic use only.
®
PRECAUTIONS
Before instilling any medication into the ear, examine the external
ear canal thoroughly to be certain the
tympanic membranes are not ruptured.
If overgrowth of non-susceptible bacteria or fungi occurs, treatment
should be discontinued and
appropriate therapy instituted.
Long-term use of topical otic corticosteroids has been associated with
adrenocortical suppression and
iatrogenic hypoadrenalcorticism in dogs.
The safe use of SUROLAN in dogs used for breeding purposes, during
pregnancy, or in lactating
bitches, has not been evalua